Skip to content
DISCOVER THE MOST SUITABLE TESTS FOR YOU
DISCOVER THE MOST SUITABLE TESTS FOR YOU
Laboratory tube with blood sample

Normocytic anemia: when erythrocytes are fewer than normal

Written by: Adrià Roca

|

Published on

|

Time to read 2 min

What is normocytic anemia?

Normocytic anemia is a type of anemia characterized by a lower-than-normal number of red blood cells that also lack the necessary amount of hemoglobin.


Anemia is a condition defined by a reduced number of healthy or normal red blood cells, a decreased concentration of hemoglobin in the blood, or a hematocrit value (normal ranges vary between 41% and 53% in men, and between 36% and 46% in women) that is below normal levels.


Red blood cells are the most abundant cells in the blood, and their primary function is to capture oxygen and transport it to different tissues throughout the body. They achieve this thanks to hemoglobin, their main protein, which binds oxygen to iron atoms, enabling its transport through the bloodstream. For this reason, anemia results in difficulty distributing oxygen to all the body's cells, as the decrease in red blood cells leads to this alteration.


The main symptoms of normocytic anemia:

    • Blood loss and hemorrhages
    • Medical conditions that impair red blood cell production
    • Medical conditions that cause red blood cell rupture (hemolysis)
    • Fatigue, low energy
    • Weakness
    • Pale skin
    • Dizziness
    • Headache
    • Difficulty concentrating
    • Lack of motivation

The main medical conditions that impair red blood cell production include:

    • Anemia of chronic disease
    • Kidney disease
    • Aplastic anemia

What are the risk factors for normocytic anemia?

The primary risk factors for normocytic anemia include all conditions that cause hemolysis or significant hemorrhages. Examples include infections, autoimmune disorders, liver diseases, and kidney diseases, among others.

How is normocytic anemia diagnosed?

Blood tests used to diagnose normocytic anemia include:

    • Complete blood count (CBC): this test provides information about hemoglobin levels and other important parameters for this type of anemia, such as mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and mean corpuscular hemoglobin concentration (MCHC), as well as other aspects of the blood
    • Peripheral blood smear: this involves examining blood cells under a microscope
    • Reticulocyte count: this test measures the number of immature red blood cells (reticulocytes) in the bone marrow

Other common tests include measurements of iron, vitamin B12, and folate levels in red blood cells.

What are the treatments for normocytic anemia?

Treatment for normocytic anemia focuses on addressing the underlying disease causing this condition. For instance, if kidney disease is the cause, treatment for that condition also helps manage normocytic anemia.

Can normocytic anemia be prevented?

Many conditions can lead to normocytic anemia, making prevention difficult. However, avoiding infections and minimizing exposure to risk factors for liver, digestive, and kidney diseases can help reduce the risk of developing normocytic anemia.

Related prevention tests

Summary

Normocytic anemia is a type of anemia characterized by lower-than-normal red blood cells that lack the necessary amount of hemoglobin. 

Red blood cells are the most abundant cells in the blood and their function is to capture oxygen for transport to different tissues throughout the body.

Anemia represents a difficulty in the distribution of oxygen to all the cells in the body since the decrease in red blood cells that it entails leads to this alteration.

The main risk factors for normocytic anemia are all those conditions that cause hemolysis or considerable bleeding.

Author

Picture of  Adrià Roca

Adrià Roca

Graduate in Biochemistry with a Master's degree in Biochemistry, Molecular Biology and Biomedicine, with a specialization in Biomolecules in Biomedical Research. Previous experience as a Laboratory Technician at Althaia (Hospital Sant Joan de Déu, Manresa). Master's Thesis developed at the Biophysics Unit (Universitat Autònoma de Barcelona), the ALBA synchrotron and at the Research Centre of l'Hospital de la Santa Creu i Sant Pau. Currently working as Director of Science and Regulatory Affairs at Blueberry Diagnostics.

Share this post